📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK. (2024)

First Author: Ladhani SN

Attributed to: MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(24)00031-8

PubMed Identifier: 38521080

Publication URI: http://europepmc.org/abstract/MED/38521080

Type: Journal Article/Review

Volume: 24

Parent Publication: The Lancet. Infectious diseases

Issue: 9

ISSN: 1473-3099